0
Phase I dose-ascending, safety, and pharmacokinetics study of APC148, a novel metallo-beta-lactamase inhibitor, in healthy volunteers. (journals.asm.org)
Authors:
Bolstad B
… Rongved P
Journal:
Antimicrobial Agents and Chemotherapy
Published:
2026-06-17
DOI:
https://doi.org/10.1128/aac.00426-26
Comments
Login to comment.
No comments yet. Be the first!